Hologic Completes Sale of LIFECODES to Immucor

                Hologic Completes Sale of LIFECODES to Immucor

PR Newswire

BEDFORD, Mass., March 22, 2013

BEDFORD, Mass., March 22, 2013 /PRNewswire/ --Hologic, Inc. (Hologic or the
Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of
premium diagnostics, medical imaging systems and surgical products dedicated
to serving the healthcare needs of women, today announced that it has
successfully completed its sale of the LIFECODES business unit to Immucor,
Inc. 

Hologic has received $85 million in cash (adjusted for working capital items)
with the opportunity to earn a contingent payment of $10 million based on the
achievement of certain financial targets for the calendar year 2013. The
closing follows the receipt of all necessary regulatory approvals.

Forward-Looking Statement Disclaimer:

This News Release contains forward-looking information that involves risks and
uncertainties, including statements about Hologic's plans, objectives,
expectations and intentions. Such statements include, without limitation,
statements about Hologic's plans, objectives, expectations and intentions, and
other statements that are not historical facts. Forward-looking statements may
contain words such as "expect," "believe," "may," "can," "should," "will,"
"forecast," "anticipate," or similar expressions (including their use in the
negative), and include assumptions that underlie such statements.These
forward-looking statements are subject to known and unknown risks and
uncertainties that could cause actual results to differ materially from those
expressed or implied by such statements, including but not limited to unknown,
underestimated or undisclosed commitments or liabilities.The risks included
above are not exhaustive. Hologic expressly disclaims any obligation or
undertaking to release publicly any updates or revisions to any such
statements presented herein to reflect any change in the Company's
expectations or any change in events, conditions or circumstances on which any
such statements are based. Certain factors that could adversely affect the
Company's business and prospects are described in Hologic's filings with the
Securities and Exchange Commission.

About Hologic, Inc.:

Hologic, Inc. is a leading developer, manufacturer and supplier of premium
diagnostic products, medical imaging systems, and surgical products.The
Company operates four core business units focused on diagnostics, breast
health, GYN surgical and skeletal health.With a comprehensive suite of
technologies and a robust research and development program, Hologic is
committed to improving lives.The Company is headquartered in Massachusetts.
For more information, visit www.hologic.com.

Hologic and associated logos are trademarks and/or registered trademarks of
Hologic, Inc. and/or its subsidiaries in the United States and/or other
countries.

Contacts:
Deborah R. Gordon     Al Kildani
Vice President, Investor Relations       Senior Director,
                                                                      Investor Relations
(781)                                                                 (858) 410-8653
999-7716
deborah.gordon@hologic.com      al.kildani@hologic.com



SOURCE Hologic, Inc.

Website: http://www.hologic.com
 
Press spacebar to pause and continue. Press esc to stop.